TITLE:
Lofexidine for Opiate Withdrawal - 1

CONDITION:
Opioid-Related Disorders

INTERVENTION:
Lofexidine

SUMMARY:

      The purpose of this study is to evaluate lofexidine for opiate withdrawal.
    

DETAILED DESCRIPTION:

      An 11 day inpatient placebo-controlled, double-blind study of 96 opiate dependent, treatment
      seeking individuals randomized to 2 medication groups: lofexidine and placebo to be
      conducted in inpatient units at 3 treatment sites.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 99 Years
Criteria:

        Inclusion Criteria:

        Male or female as least 18 yrs of age & above with a current dependence on heroin,
        morphine or hydromorphone according to DSM4 criteria; subject ; voluntarily given consent
        and signed informed consent; females using appropriate birth control method.

        Exclusion Criteria:

        Additional criteria available during screening at the site
      
